Biogen, Inc. (BIIB)
180.44
-0.86
(-0.47%)
USD |
NASDAQ |
Dec 08, 16:00
180.60
+0.16
(+0.09%)
After-Hours: 20:00
Biogen Research and Development Expense (Quarterly): 369.60M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.90B |
| Eli Lilly & Co. | 3.466B |
| Merck & Co., Inc. | 3.552B |
| Pfizer Inc. | 2.492B |
| Stoke Therapeutics, Inc. | 37.25M |